KTTA - Pasithea Therapeutics Corp.
Previous close
2.79
0 0%
Share volume: 200
Last Updated: Thu 26 Dec 2024 09:30:48 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$2.79
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-16 | 2022-08-15 | 2022-11-14 | 2023-03-30 | 2023-05-12 | 2023-08-11 | 2023-11-13 | |
| Total revenue | 13.658 K | 13.581 K | 218.608 K | 240.712 K | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 12.937 K | 15.101 K | 86.465 K | -1.308 K | 0.000 | 0.000 | 0.000 | |
| Gross profit | 721.000 | -1.520 K | 132.143 K | 242.020 K | 0.000 | 0.000 | 0.000 | |
| -310.82% | 8,793.62% | 83.15% | -100.00% | nan% | nan% | |||
| Operating expenses | 2.405 M | 3.079 M | 4.383 M | 5.323 M | 3.213 M | 3.829 M | 3.789 M | |
| Selling general and admin | 2.405 M | 3.079 M | 3.224 M | 3.816 M | 2.116 M | 1.801 M | 2.165 M | |
| Research and development | 0.000 | 0.000 | 1.159 M | 1.506 M | 1.096 M | 2.028 M | 1.625 M | |
| Total expenses | 2.418 M | 3.094 M | 4.469 M | 5.322 M | 3.213 M | 3.829 M | 3.789 M | |
| 27.93% | 44.47% | 19.07% | -39.63% | 19.18% | -1.03% | |||
| Operating income | -2.405 M | -3.080 M | -4.251 M | -5.081 M | -3.213 M | -3.829 M | -3.789 M | |
| Ebit | -2.405 M | -3.080 M | -4.251 M | -5.081 M | -3.213 M | -3.829 M | -3.789 M | |
| Pretax income | -1.574 M | -2.658 M | -4.586 M | -5.118 M | -3.266 M | -3.598 M | -3.613 M | |
| 68.87% | 72.52% | 11.59% | -36.19% | 10.17% | 0.40% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -1.574 M | -2.658 M | -4.586 M | -5.118 M | -3.538 M | -3.763 M | -3.613 M | |
| -68.87% | -72.52% | -11.59% | 30.87% | -6.38% | 4.00% | |||
| Net income | -1.574 M | -2.658 M | -4.586 M | -5.118 M | -3.538 M | -3.763 M | -3.613 M | |
| -68.87% | -72.52% | -11.59% | 30.87% | -6.38% | 4.00% |